TrialAnnals of surgical oncology2025

An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.

Jonathan S Zager et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.